Tevogen announces annual shareholder meeting
TVGN•Items to be voted on
Shareholders will vote to elect two Class II directors: Dr. Keow Lin Goh and Victor Sordillo.
They will also vote on ratifying KPMG as independent registered public accounting firm for the year ending Dec. 31, 2026.
Other items scheduled for a vote include amending the 2024 Omnibus Incentive Plan to add 100,000,000 shares for equity awards and a charter amendment to allow shareholder action by written consent.
Annual meeting details
Tevogen Bio Holdings will hold its 2026 annual shareholder meeting on Aug. 24, 2026 in a virtual format.
